The University of Chicago Header Logo

Novel Therapeutic Targets and Immune Dysfunction in Malignant Pleural Mesothelioma.

Novel Therapeutic Targets and Immune Dysfunction in Malignant Pleural Mesothelioma. Front Pharmacol. 2021; 12:806570.

View in: PubMed